We are live on ! Find out more
MORF

Morphic Holding, Inc. Common Stock

Delisted

MORF was delisted on the 15th of August, 2024.

134 hedge funds and large institutions have $935M invested in Morphic Holding, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 62 increasing their positions, 32 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 32

43% more call options, than puts

Call options by funds: $11.2M | Put options by funds: $7.84M

12% less funds holding

Funds holding: 152134 (-18)

38% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 42

58% less capital invested

Capital invested by funds: $2.22B → $935M (-$1.28B)

67% less funds holding in top 10

Funds holding in top 10: 93 (-6)

Holders
134
Holders Change
-18
Holders Change %
-11.84%
% of All Funds
2.13%
Holding in Top 10
3
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-66.67%
% of All Funds
0.05%
New
26
Increased
62
Reduced
32
Closed
42
Calls
$11.2M
Puts
$7.84M
Net Calls
+$3.34M
Net Calls Change
-$9.34M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$6.97M +$1.96M +37,264 +14%
AAA
27
Affinity Asset Advisors
New York
$6.19M +$3.57M +68,113 +34%
CS
28
Candriam SCA
Luxembourg
$5.73M
DCM
29
DAFNA Capital Management
California
$5.31M +$1.31M +25,000 +12%
BBA
30
Baker Bros. Advisors
New York
$4.94M +$11.3M +215,800 New
FT
31
Fiduciary Trust
Massachusetts
$4.91M
Ensign Peak Advisors
32
Ensign Peak Advisors
Utah
$4.82M -$60.4K -1,150 -0.5%
O
33
OrbiMed
New York
$4.78M
MB
34
MPM BioImpact
Massachusetts
$4.58M +$10.5M +200,000 New
Balyasny Asset Management
35
Balyasny Asset Management
Illinois
$4.31M +$9.86M +187,970 New
Two Sigma Advisers
36
Two Sigma Advisers
New York
$3.92M +$8.75M +166,700 +3,704%
Walleye Capital
37
Walleye Capital
New York
$3.91M +$8.95M +170,599 New
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$3.3M -$1.19M -22,650 -14%
DCM
39
Driehaus Capital Management
Illinois
$3.19M -$22.7M -431,932 -76%
Rafferty Asset Management
40
Rafferty Asset Management
New York
$3.19M +$473K +9,013 +7%
SVCM
41
Saturn V Capital Management
Texas
$3.13M -$820K -15,617 -10%
FAM
42
Fred Alger Management
New York
$3.04M +$1.88M +35,793 +37%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$2.84M +$718K +13,686 +12%
Bank of America
44
Bank of America
North Carolina
$2.79M +$261K +4,966 +4%
TC
45
TwinBeech Capital
New York
$2.74M +$6.29M +119,778 New
Assenagon Asset Management
46
Assenagon Asset Management
Luxembourg
$2.71M +$2.7M +51,521 +77%
N
47
Nuveen
North Carolina
$2.57M -$5.46M -104,098 -48%
Jane Street
48
Jane Street
New York
$2.52M +$4.54M +86,580 +369%
Voloridge Investment Management
49
Voloridge Investment Management
Florida
$2.5M +$2.35M +44,852 +70%
SSA
50
Schonfeld Strategic Advisors
New York
$2.49M +$4.17M +79,398 +273%

MORF Hedge Fund Activity: Q3 2023 in Review

134 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Morphic Holding, Inc. Common Stock (MORF) for Q3 2023, worth a combined $935M — down 58% from $2.22B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of MORF and 26 opened new positions — a net loss of 16 holders — while 32 trimmed existing stakes and 62 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $131M. The largest seller was EcoR1 Capital, cutting an estimated $124M.

  • 134 institutional investors held Morphic Holding, Inc. Common Stock (MORF) as of Q3 2023, down from 152 in Q2 2023.
  • Funds reported $935M of Morphic Holding, Inc. Common Stock stock for Q3 2023, down 58% quarter-over-quarter.
  • 26 funds opened new Morphic Holding, Inc. Common Stock positions in Q3 2023 and 42 closed out, a net change of -16 holders.
  • The largest Morphic Holding, Inc. Common Stock buyer in Q3 2023 was Point72 Asset Management, an estimated $131M added.
  • The largest Morphic Holding, Inc. Common Stock seller in Q3 2023 was EcoR1 Capital, an estimated $124M sold.

Based on aggregated 13F filings for Q3 2023.